Pension fund sues BioPharma board due to COVID-Vax fiasco



Law360 (June 30, 2021, 8:13 p.m. EDT) – An Illinois pension fund hit senior directors of Emergent BioSolutions Inc. in a derivative lawsuit alleging that board members made a coin sale of stocks before their lax oversight for contamination of over 15. Have resulted in millions of Johnson & Johnson COVID-19 vaccine doses.

Lincolnshire Police Pension filed a lawsuit in federal court in Maryland on Tuesday alleging that Emergent executives had breached their fiduciary duty by making the facility operate without proper quality controls and under-trained staff, costing hundreds of millions of dollars after the J. & J contamination became known, the lawsuit states.

AstraZeneca and J&J chose Emergent to manufacture their vaccines in deals that each …

Stay ahead of the curve

In the legal profession, information is the key to success. You need to know what is happening to customers, competitors, practice areas and industries. Law360 offers the intelligence you need to stay an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, type of lawsuit, etc.)
  • Access to attached documents such as Briefs, petitions, complaints, decisions, motions, etc.
  • Create custom notifications for specific article and case topics, and more!



Leave A Reply

Your email address will not be published.